首页> 外文会议>International Conference on Science and Technology >Synthesis /V-Phenyl Pyrazoline from Dibenzalacetone and Heme Polymeration Inhibitory Activity (HPIA) Assay
【24h】

Synthesis /V-Phenyl Pyrazoline from Dibenzalacetone and Heme Polymeration Inhibitory Activity (HPIA) Assay

机译:来自二苯甲酸盐和血红素聚合物抑制活性(HPIA)测定的合成/ V-苯基吡唑啉

获取原文

摘要

The synthesis of 1,5-diphenyl-3-styryl-4,5-dihydro-1H-pyrazole (Bl) and 5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-1-phenyl-4,5-dihydro-1H-pyrazole (B2) have been conducted from 1,5-diphenylpenta-1,4-dien-3-on (Al) and 1,5-bis(3,4-dimethoxyphenyl)penta-1,4-dien-3-one (A2). Heme polymerization inhibitory activity (HPIA) assay of the synthesized compounds has also been carried out. The first step of reaction was Claisen-Schmidt condensation of benzaldehyde derivatives and acetone using NaOH 20% and ethanol as solvent. Dibenzalacetone derivatives were reacted with phenylhydrazine using acetic acid to form N-phenylpyrazoline. The structure of products was characterized by FT-IR, GC-MS, DI-MS, ~1H- and ~(13)C-NMR The result of heme polymerization inhibitory activity assay showed that IC50 of Bl and B2 1.26 and 0.79 mM while quinine 1.26 mM. The result indicated that compound B2 was more potent as antimalarial than quinine.
机译:合成1,5-二苯基-3- styryl-4,5-二氢-1H-吡唑(B1)和5-(3,4-二甲氧基苯基)-3-(3,4-二甲氧基苯基)-1-苯基 - 4,5-二羟基-1H-吡唑(B2)已从1,5-二苯基戊基-1,4-DIEN-3-ON(Al)和1,5-双(3,4-二甲氧基苯基)Penta-1中进行,4-dien-3-one(a2)。还进行了合成化合物的血红素聚合抑制活性(HPIA)测定。第一步是使用NaOH 20%和乙醇作为溶剂的苯甲醛衍生物和丙酮的第一个反应步骤。使用乙酸与苯基肼反应以形成N-苯基吡唑啉。产品的结构特征在于FT-IR,GC-MS,DI-MS,〜1H-和〜(13)C-NMR血红素聚合抑制活性测定的结果显示,BL和B2 1.26和0.79mm的IC50奎宁1.26毫米。结果表明,化合物B2比奎宁更有效地抗疟药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号